Full-Time

Vice President

Commercial

Inizio

Inizio

5,001-10,000 employees

Guides clinical development and commercialization

Compensation Overview

$180k - $220k/yr

Remote in USA + 5 more

More locations: San Francisco, CA, USA | Philadelphia, PA, USA | Newtown, PA, USA | York, PA, USA | New York, NY, USA

Hybrid

Hybrid role: remote from USA with on-site at NYC, Yardley, York, or San Francisco offices.

Category
Sales & Account Management (1)
Requirements
  • Strong results orientation with a proven track record of driving strategic business development, both in new clients and in growing the account size (breadth and depth) within existing clients.
  • Self-motivated, relishes new challenges in a dynamic environment and demonstrates an intense drive to generate superior outcomes.
  • Analytical and problem-solving capability with an ability to think laterally and creatively.
  • Capable and supportive team member, can adapt approach to colleagues according to personality and cultural differences, and can lead and influence colleagues who are not reports.
  • Collaborative, can demonstrate a team before self-approach, knowing when to delegate and when to take ownership, to ensure the team benefits first.
  • Exceptional project management and time management skills coupled with deep market and product understanding.
  • Ability to work collaboratively at all levels and network effectively within the broader cross-functional Inizio matrix.
  • Line management capabilities and experience of coaching successful mid-senior level business development and commercial professionals
  • Confident and articulate verbal and written communicator, with an ability to foster productive relationships at senior management level.
  • Demonstrates judgment, pragmatism and commercially astute approach to decision making and is also responsive to alternate views.
  • Employs influence and tact to resolve issues, conflict and promote effective teamwork and supports innovation amongst team to meet objectives.
  • Effective team, peer and cross functional team coach able to provide broader organisational support as required.
  • An excellent communicator with exceptional presentation skills and influencing skills.
Responsibilities
  • You will own, coordinate and execute the global business development strategy, plan and activities on designated global pharmaceutical and biotech accounts in order to meet Inizio Ignite RP and STEM sales and revenue targets.
  • You will work directly and indirectly coordinating and supporting all BD activities in partnership with the Inizio Ignite Innovation & Growth team to increase awareness, access, and sales for RP, STEM and Inizio for the accounts they are accountable for.
  • You will represent the customer within Inizio Insights, create, communicate, and execute a customer centric value proposition internally and externally to become a trusted partner.
  • You will partner with other SVPs, VPs and account managers across the Inizio Ignite RP and STEM teams to embed commercial best practices and drive key account growth initiatives in a collaborative fashion.
  • Lead and co-ordinate business development activities within the assigned target client accounts, this includes winning new and repeat business, and expanding RP, STEM and Inizio business across new services and new geographies (breadth and depth).
  • Take accountability for account targets and support delivery through coordination with global and regional delivery teams.
  • The individual must develop strong relationships with key stakeholders within the target accounts, ensuring that a partnership is built that facilitates maintenance and growth of target accounts. Key external stakeholders range from senior functional heads such within sales, insights/business intelligence, marketing, SFE, medical excellence, global brand leads, global medical leaders through to CEOs
  • Partnering with the operational account leadership to support critical service delivery deliverables including result presentations and action planning for future projects and services.
  • Acting as a point of escalation for all customer stakeholders
Desired Qualifications
  • You are proactive, dedicated, and enthusiastic
  • You demonstrate a high level of strategic thinking and judgement, capable of identifying and developing commercial opportunities
  • You are a collaborative leader who empowers your direct and indirect reports to deliver exceptional work, and to take the initiative and seize opportunities for growth
  • You communicate ideas and issues in an effective, straightforward fashion
  • You are highly motivated and are looking for an opportunity to step into a key, high profile role in our organization

Inizio helps health and life sciences companies develop and commercialize products to maximize patient access. It uses a connected suite of capabilities and expert guidance to navigate assets through their entire lifecycle with tailored strategies. Unlike firms that offer single services, Inizio combines multiple capabilities in an end-to-end approach focused on reducing complexity and ensuring lifecycle support. Its goal is to bring therapies to patients faster and more effectively by coordinating development, regulatory, market access, and commercialization activities to maximize value and treatment outcomes.

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Colin Stanley's CCO appointment on February 6, 2025, drives commercialization growth with 25 years' experience.
  • Patrick Giordani as SVP AI Solutions Architect bolsters AI innovation in medical affairs communications.
  • Nazaré unites 150 experts to enhance employee performance via immersive learning experiences.

What critics are saying

  • Intelligent Automation Congress on March 3-4, 2026, erodes edge with superior AI event automation.
  • Nazaré launch cannibalizes Intelligent Congress budgets, diverting funds to internal learning.
  • Patrick Giordani's AI fails by end-2026, causing client exodus to IA Congress AI networks.

What makes Inizio unique

  • Intelligent Congress integrates strategy, design, delivery, and measurement across congress lifecycles.
  • Inizio supports 175 congresses yearly for 100% of top 20 pharma companies across 50 countries.
  • Four-step framework captures real-time insights from over 25,500 attendees and 1,000 HCP engagements.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Inizio who can refer or advise you

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Professional Development Budget

Hybrid Work Options

Company News

PR Newswire
Feb 6th, 2025
Inizio Accelerates Growth With A Trio Of Strategic Leadership Appointments

LONDON, Feb. 6, 2025 /PRNewswire/ -- Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.Stepping into the CCO role, Colin brings over 25 years of sector experience and a proven track record in business growth in the industry, from CRO and commercialization

Bio-IT World
Oct 20th, 2024
Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

Inizio Medical, the leading provider of Medical Affairs and communications solutions, today announced the appointment of Patrick Giordani as Senior Vice President, AI Solutions Architect.

Bio-IT World
Oct 14th, 2024
Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs

Bio-IT World Inc is immensely proud that Matt has chosen to join Inizio Medical and contribute to its mission of providing exceptional medical communications and specialized solutions.

PR Newswire
Oct 18th, 2023
Inizio Engage Launches New Global Powerhouse Learning Brand, Nazaré

FORT WASHINGTON, Pa., Oct. 18, 2023 /PRNewswire/ -- Inizio Engage has announced the launch of Nazaré, a new learning and capability brand. Nazaré brings together 150+ experts in learning, life sciences, creativity, technology, and behavioral science. Nazaré is set to transform workplace learning in order to help companies maintain their leadership in evolving competitive landscapes by unlocking the potential of their people.The new global learning and capability brand will be part of the Experience Design (XD) specialist area within Inizio Engage. This means Nazaré will draw on the rest of Inizio Engage XD's in-house creative and executional capabilities in live events, environments, film, digital, and immersive technologies, as well as considering learning experience design more holistically alongside employee engagement.Nazaré brings together Axiom, Cormis, Logicearth Learning Services and Ashfield Excellence Academy under one brand to support global organizations with a range of learning and capability programs, with an unparalleled level of expertise in end-to-end life sciences learning support for pharmaceutical and biotech companies across the product lifecycle. Nazaré will focus on designing and delivering world-class learning experiences that inspire an immediate and lasting change in performance.Nazaré harnesses science, creativity, and technology to challenge how the Learning & Development industry creates impact for businesses

PR Newswire
Sep 14th, 2023
Innovative Collaboration: Buzzreach And Oncoshot Spearhead Clinical Trial Advancements In Japan

SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specialises in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform.Mr Taketeru Inokawa (left) and Dr Huren Sivaraj (right) during the MOU signing ceremony in Singapore.The collaboration will extend to Oncoshot's strategic contract research organisation and pharmaceutical partners. Together, they will focus on recruiting participants for upcoming studies scheduled to begin in Q1 2024."This collaboration marks a significant step in Oncoshot's vision of creating a cancer cohort discovery platform and upcoming national-level clinical trials ecosystems and hospitals globally," said Oncoshot CEO Dr Huren Sivaraj.Central to this partnership is the cost-free infrastructure designed to facilitate the real-time exchange of aggregated insights. This ground-breaking initiative is set to synergise their complementary strengths to enhance various clinical trial aspects throughout Japan, including feasibility assessments, participant screening, and enrolment. Japan is currently ranked as the third-largest pharmaceutical market worldwide